145 related articles for article (PubMed ID: 20827782)
1. Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study.
Simard JF; Neovius M; Hagelberg S; Askling J
Arthritis Rheum; 2010 Dec; 62(12):3776-82. PubMed ID: 20827782
[TBL] [Abstract][Full Text] [Related]
2. Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents.
Nordstrom BL; Mines D; Gu Y; Mercaldi C; Aquino P; Harrison MJ
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1357-64. PubMed ID: 22511558
[TBL] [Abstract][Full Text] [Related]
3. Malignancies in juvenile idiopathic arthritis: a preliminary report.
Bernatsky S; Rosenberg AM; Oen KG; Duffy CM; Ramsey-Goldman R; Labrecque J; St Pierre Y; Clarke AE
J Rheumatol; 2011 Apr; 38(4):760-3. PubMed ID: 21239753
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study.
Skarin A; Elborgh R; Edlund E; Bengtsson-Stigmar E
Ocul Immunol Inflamm; 2009; 17(2):104-8. PubMed ID: 19412872
[TBL] [Abstract][Full Text] [Related]
6. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss.
Thorne JE; Woreta F; Kedhar SR; Dunn JP; Jabs DA
Am J Ophthalmol; 2007 May; 143(5):840-846. PubMed ID: 17362866
[TBL] [Abstract][Full Text] [Related]
7. Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents.
Saurenmann RK; Levin AV; Feldman BM; Laxer RM; Schneider R; Silverman ED
J Pediatr; 2006 Dec; 149(6):833-6. PubMed ID: 17137902
[TBL] [Abstract][Full Text] [Related]
8. Report on malignancies in the German juvenile idiopathic arthritis registry.
Horneff G; Foeldvari I; Minden K; Moebius D; Hospach T
Rheumatology (Oxford); 2011 Jan; 50(1):230-6. PubMed ID: 21148157
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database].
Heiligenhaus A; Niewerth M; Mingels A; Ganser G; Thon A; Pleyer U; Greiner K; Minden K
Klin Monbl Augenheilkd; 2005 Dec; 222(12):993-1001. PubMed ID: 16418970
[TBL] [Abstract][Full Text] [Related]
10. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland.
Bolt IB; Cannizzaro E; Seger R; Saurenmann RK
J Rheumatol; 2008 Apr; 35(4):703-6. PubMed ID: 18278829
[TBL] [Abstract][Full Text] [Related]
12. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.
Simon D; Fernando C; Czernichow P; Prieur AM
J Rheumatol; 2002 Jun; 29(6):1296-300. PubMed ID: 12064849
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry.
Pallavicini FB; Caporali R; Sarzi-Puttini P; Atzeni F; Bazzani C; Gorla R; Marchesoni A; Favalli EG; Montecucco C
Autoimmun Rev; 2010 Jan; 9(3):175-80. PubMed ID: 19647103
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis.
Goebel JC; Roesel M; Heinz C; Michels H; Ganser G; Heiligenhaus A
Br J Ophthalmol; 2011 Feb; 95(2):209-13. PubMed ID: 20584711
[TBL] [Abstract][Full Text] [Related]
15. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
16. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis.
Kalinina Ayuso V; Ten Cate HA; van der Does P; Rothova A; de Boer JH
Am J Ophthalmol; 2010 Jun; 149(6):994-999.e5. PubMed ID: 20510688
[TBL] [Abstract][Full Text] [Related]
17. Temporomandibular joint involvement in children with juvenile idiopathic arthritis.
Cannizzaro E; Schroeder S; Müller LM; Kellenberger CJ; Saurenmann RK
J Rheumatol; 2011 Mar; 38(3):510-5. PubMed ID: 21159837
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis.
Saurenmann RK; Levin AV; Feldman BM; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2010 Jun; 62(6):1824-8. PubMed ID: 20178126
[TBL] [Abstract][Full Text] [Related]
19. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.
Bensing S; Brandt L; Tabaroj F; Sjöberg O; Nilsson B; Ekbom A; Blomqvist P; Kämpe O
Clin Endocrinol (Oxf); 2008 Nov; 69(5):697-704. PubMed ID: 18727712
[TBL] [Abstract][Full Text] [Related]
20. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.
Kump LI; Castañeda RA; Androudi SN; Reed GF; Foster CS
Ophthalmology; 2006 Oct; 113(10):1874-7. PubMed ID: 16884776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
